Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur
Condition(s) studied
Investigational drug(s) / intervention(s)
Analysis: Analysis and review of imaging and clinical data
Study summary
The investigators will collect data of patients treated surgically for impending or pathological fracture of the proximal femur due to bone metastases between 01/01/2000 and 31/12/2023 with IMN or THA or HHA or MegaTHA or Mega.
After pre-screening the databases of the respective sites, the investigators expect to find approximately a total of 600 patients. A review will be made from the medical records, radiological imaging, and histological data of partecipants.
Eligibility
Primary outcome measure(s)
- Analysis of implant survival — through study completion, an average of 1 year
Assess the longevity associated with the different surgical treatments used for proximal femur bone metastases. - Analysis of complications — At baseline ( T0)
Assess the post-operative complications associated with the different surgical treatments used for proximal femur bone metastases. - Analysis of functional score — 1 year
Assess the functional score associated with the different surgical treatments used for proximal femur bone metastases.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Irccs Istituto Ortopedico Rizzoli | Bologna | Emilia-Romagna | Recruiting |
More Costantino Errani trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06918860 on ClinicalTrials.gov ↗ ← All trials in Italy